Enzo Spisni is an associate professor and head of the Laboratory of Translational Physiology and Nutrition at the Department of Biological, Geological, and Environmental Sciences, University of Bologna. He is a member of the scientific committee of the Master's (level II) in Nutrition and Education on Health, University of Bologna, and a lecturer for the Master's in Organic Production at the same university. Since 2008, he has been collaborating with specialists in the gastrointestinal tract on various projects aimed at understanding the alteration of the physiological mechanisms involved in the onset of intestinal and systemic pathologies through the study of translational physiology. He received the National Qualification for a full professor on 8/3/2018. He collaborates with various companies in the food sector and the food supplement sector. From 2015 to 2021, he was CEO of the spin-off Targeting Gut Disease Srl, which deals with the study and formulation of innovative food supplements aimed at modulating intestinal and systemic physiology. In July 2020, Targeting Gut Disease won a European project for the production of a food supplement capable of improving immune responses against Sars-Cov-2. Since 2019, he has been a member of the scientific committee of Good Land, a multidisciplinary collective aimed at experimenting with new models of agri-food regeneration.
Research Keywords & Expertise
Nutrition
Intestinal Microbiome
cellular physiology
Intestinal Barrier
Food science
Fingerprints
8%
Nutrition
5%
Intestinal Barrier
Short Biography
Enzo Spisni is an associate professor and head of the Laboratory of Translational Physiology and Nutrition at the Department of Biological, Geological, and Environmental Sciences, University of Bologna. He is a member of the scientific committee of the Master's (level II) in Nutrition and Education on Health, University of Bologna, and a lecturer for the Master's in Organic Production at the same university. Since 2008, he has been collaborating with specialists in the gastrointestinal tract on various projects aimed at understanding the alteration of the physiological mechanisms involved in the onset of intestinal and systemic pathologies through the study of translational physiology. He received the National Qualification for a full professor on 8/3/2018. He collaborates with various companies in the food sector and the food supplement sector. From 2015 to 2021, he was CEO of the spin-off Targeting Gut Disease Srl, which deals with the study and formulation of innovative food supplements aimed at modulating intestinal and systemic physiology. In July 2020, Targeting Gut Disease won a European project for the production of a food supplement capable of improving immune responses against Sars-Cov-2. Since 2019, he has been a member of the scientific committee of Good Land, a multidisciplinary collective aimed at experimenting with new models of agri-food regeneration.